Evidence map›Paper›PMID 24878844›Full record

ArticlePloS one2014

Dose-response of superparamagnetic iron oxide labeling on mesenchymal stem cells chondrogenic differentiation: a multi-scale in vitro study.

Emilie Roeder, Christel Henrionnet, Jean Christophe Goebel, Nicolas Gambier, Olivier Beuf, Denis Grenier, Bailiang Chen, Pierre-André Vuissoz, Pierre Gillet, Astrid Pinzano

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. A primer onFrontiers in medicine · 2023
    Review
  3. Article
  4. Advanced functional materials · 2022
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Tracking Cell Transplants in Femoral Osteonecrosis with Magnetic Resonance Imaging: A Proof-of-Concept Study in Patients.Clinical cancer research : an official journal of the American Association for Cancer Research · 2018
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Imaging Biomaterial-Tissue Interactions.Trends in biotechnology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Emilie RoederIngénierie Moléculaire et Physiopathologie Articulaire - Unité Mixte de Recherches 7365 Centre National de la Recherche Scientifique - Université de Lorraine, Vandoeuvre Lès Nancy, France.
Christel HenrionnetIngénierie Moléculaire et Physiopathologie Articulaire - Unité Mixte de Recherches 7365 Centre National de la Recherche Scientifique - Université de Lorraine, Vandoeuvre Lès Nancy, France.
Jean Christophe GoebelCentre de Recherche en Acquisition et Traitement de l'Image pour la Santé, Centre National de la Recherche Scientifique 5220, Institut National de la Santé et de la Recherche Médicale U1044, Université de Lyon, Institut National des Sciences Appliquées de Lyon, Villeurbanne, France.
Nicolas GambierIngénierie Moléculaire et Physiopathologie Articulaire - Unité Mixte de Recherches 7365 Centre National de la Recherche Scientifique - Université de Lorraine, Vandoeuvre Lès Nancy, France.
Olivier BeufCentre de Recherche en Acquisition et Traitement de l'Image pour la Santé, Centre National de la Recherche Scientifique 5220, Institut National de la Santé et de la Recherche Médicale U1044, Université de Lyon, Institut National des Sciences Appliquées de Lyon, Villeurbanne, France.
Denis GrenierCentre de Recherche en Acquisition et Traitement de l'Image pour la Santé, Centre National de la Recherche Scientifique 5220, Institut National de la Santé et de la Recherche Médicale U1044, Université de Lyon, Institut National des Sciences Appliquées de Lyon, Villeurbanne, France.
Bailiang ChenImagerie Adaptative Diagnostique Interventionelle, Institut National de la Santé et de la Recherche Médicale U947, Vandoeuvre-Lès-Nancy, France.
Pierre-André VuissozImagerie Adaptative Diagnostique Interventionelle, Institut National de la Santé et de la Recherche Médicale U947, Vandoeuvre-Lès-Nancy, France.
Pierre GilletIngénierie Moléculaire et Physiopathologie Articulaire - Unité Mixte de Recherches 7365 Centre National de la Recherche Scientifique - Université de Lorraine, Vandoeuvre Lès Nancy, France.
Astrid PinzanoIngénierie Moléculaire et Physiopathologie Articulaire - Unité Mixte de Recherches 7365 Centre National de la Recherche Scientifique - Université de Lorraine, Vandoeuvre Lès Nancy, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe aim of this work was the development of successful cell therapy techniques for cartilage engineering. This will depend on the ability to monitor non-invasively transplanted cells, especially mesenchymal stem cells (MSCs) that are promising candidates to regenerate damaged tissues.

methodsMSCs were labeled with superparamagnetic iron oxide particles (SPIO). We examined the effects of long-term labeling, possible toxicological consequences and the possible influence of progressive concentrations of SPIO on chondrogenic differentiation capacity.

resultsNo influence of various SPIO concentrations was noted on human bone marrow MSC viability or proliferation. We demonstrated long-term (4 weeks) in vitro retention of SPIO by human bone marrow MSCs seeded in collagenic sponges under TGF-β1 chondrogenic conditions, detectable by Magnetic Resonance Imaging (MRI) and histology. Chondrogenic differentiation was demonstrated by molecular and histological analysis of labeled and unlabeled cells. Chondrogenic gene expression (COL2A2, ACAN, SOX9, COL10, COMP) was significantly altered in a dose-dependent manner in labeled cells, as were GAG and type II collagen staining. As expected, SPIO induced a dramatic decrease of MRI T2 values of sponges at 7T and 3T, even at low concentrations.

conclusionsThis study clearly demonstrates (1) long-term in vitro MSC traceability using SPIO and MRI and (2) a deleterious dose-dependence of SPIO on TGF-β1 driven chondrogenesis in collagen sponges. Low concentrations (12.5-25 µg Fe/mL) seem the best compromise to optimize both chondrogenesis and MRI labeling.

Indexed as

Bone MarrowCartilageCell DifferentiationCell ProliferationCells, CulturedCell SurvivalChondrocytesChondrogenesisCollagen Type IIFerric CompoundsGene ExpressionHumansIn Vitro TechniquesMagnetic Resonance ImagingMesenchymal Stem CellsMesenchymal Stem Cell TransplantationCollagen Type IIFerric Compoundsferric oxideTransforming Growth Factor beta1

Identifiers

PMID24878844
PMCPMC4039474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.